loadpatents
name:-0.050808906555176
name:-0.029567003250122
name:-0.0091500282287598
Markel; Gal Patent Filings

Markel; Gal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Markel; Gal.The latest application filed is for "anti-hvem antibodies and use thereof".

Company Profile
13.47.64
  • Markel; Gal - Haifa IL
  • Markel; Gal - Ramat Gan IL
  • MARKEL; Gal - Tel Aviv IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
CEACAM based antibacterial agents
Grant 11,433,113 - Markel September 6, 2		2022-09-06
Polynucleotides encoding humanized antibodies against CEACAM1
Grant 11,427,647 - Ben-Moshe , et al. August 30, 2		2022-08-30
Anti-hvem Antibodies And Use Thereof
App 20220227879 - GREENBERG; Eyal ;   et al.		2022-07-21
Mobile Communication Device And Other Devices With Cardiovascular Monitoring Capability
App 20220175248 - Markel; Gal		2022-06-09
Mobile communication device and other devices with cardiovascular monitoring capability
Grant 11,298,020 - Markel April 12, 2		2022-04-12
Ceacam1 Mediated Protective Immunity
App 20220001042 - MARKEL; GAL		2022-01-06
Ceacam1 Based Cancer Therapy And Diagnosis
App 20220001041 - Markel; Gal		2022-01-06
Wearable Items Providing Physiological, Environmental And Situational Parameter Monitoring
App 20210212398 - Markel; Gal		2021-07-15
Wearable items providing physiological, environmental and situational parameter monitoring
Grant 10,993,490 - Markel May 4, 2		2021-05-04
Ceacam Based Antibacterial Agents
App 20210106647 - Markel; Gal		2021-04-15
Antibodies To Carcinoembryonic Antigen-related Cell Adhesion Molecule (ceacam)
App 20210070884 - MARKEL; Gal ;   et al.		2021-03-11
Ceacam1 Based Point-of-care Cancer Diagnostic
App 20200393459 - Markel; Gal		2020-12-17
CEACAM based antibacterial agents
Grant 10,765,719 - Markel Sep		2020-09-08
Humanized Antibodies Against Ceacam1
App 20200277398 - BEN-MOSHE; Tehila ;   et al.		2020-09-03
Humanized Antibodies Against Ceacam1
App 20200216557 - BEN-MOSHE; Tehila ;   et al.		2020-07-09
CEACAM1 based point-of-care cancer diagnostic
Grant 10,663,464 - Markel		2020-05-26
Humanized antibodies against CEACAM1
Grant 10,550,196 - Ben-Moshe , et al. Fe		2020-02-04
Modulation Of Immunity And Ceacam1 Activity
App 20190374662 - Markel; Gal		2019-12-12
Wearable Items Providing Physiological, Environmental And Situational Parameter Monitoring
App 20190125262 - Markel; Gal		2019-05-02
Modulation of immunity and CEACAM1 activity
Grant 10,188,760 - Markel Ja		2019-01-29
Wearable items providing physiological, environmental and situational parameter monitoring
Grant 10,105,097 - Markel October 23, 2		2018-10-23
Ceacam Based Antibacterial Agents
App 20180250353 - Markel; Gal		2018-09-06
Ceacam1 Based Cancer Therapy And Diagnosis
App 20180185525 - Markel; Gal		2018-07-05
Ceacam1 Mediated Protective Immunity
App 20180177902 - MARKEL; GAL		2018-06-28
CEACAM based antibacterial agents
Grant 9,889,175 - Markel February 13, 2		2018-02-13
Anti Ceacam1 Antibodies And Methods Of Using Same
App 20180016338 - MARKEL; Gal ;   et al.		2018-01-18
Antibodies To Carcinoembryonic Antigen-related Cell Adhesion Molecule (ceacam)
App 20170355781 - MARKEL; Gal ;   et al.		2017-12-14
CEACAM1 based cancer therapy and diagnosis
Grant 9,795,696 - Markel October 24, 2		2017-10-24
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)
Grant 9,771,431 - Markel , et al. September 26, 2		2017-09-26
CEACAM1 mediated protective immunity
Grant 9,731,036 - Markel August 15, 2		2017-08-15
CEACAM based antibacterial agents
Grant 9,694,046 - Markel July 4, 2		2017-07-04
Wearable Items Providing Physiological, Environmental And Situational Parameter Monitoring
App 20170172503 - Markel; Gal		2017-06-22
Mobile Communication Device And Other Devices With Cardiovascular Monitoring Capability
App 20170143205 - Markel; Gal		2017-05-25
Humanized Antibodies Against Ceacam1
App 20170044270 - BEN-MOSHE; Tehila ;   et al.		2017-02-16
Antibodies To Ceacam1 And Kinase Inhibitors For Treating Braf-mutated Cells
App 20160376374 - Markel; Gal ;   et al.		2016-12-29
Wearable items providing physiological, environmental and situational parameter monitoring
Grant 9,526,452 - Markel December 27, 2		2016-12-27
Mobile communication device and other devices with cardiovascular monitoring capability
Grant 9,451,895 - Markel September 27, 2		2016-09-27
Ceacam Based Antibacterial Agents
App 20160271204 - MARKEL; GAL		2016-09-22
Anti Ceacam1 Antibodies And Methods Of Using Same
App 20160176966 - Markel; Gal ;   et al.		2016-06-23
Wearable Items Providing Physiological, Environmental And Situational Parameter Monitoring
App 20160100798 - Markel; Gal		2016-04-14
Anti CEACAM1 antibodies and methods of using same
Grant 9,261,507 - Markel , et al. February 16, 2		2016-02-16
Microrna patterns for the diagnosis, prognosis and treatment of melanoma
Grant 9,238,838 - Markel , et al. January 19, 2		2016-01-19
Wearable items providing physiological, environmental and situational parameter monitoring
Grant 9,131,892 - Markel September 15, 2		2015-09-15
Modulation Of Immunity And Ceacam1 Activity
App 20150174274 - Markel; Gal		2015-06-25
Ceacam1 Mediated Protective Immunity
App 20150150912 - MARKEL; GAL		2015-06-04
MicroRNA patterns for the diagnosis, prognosis and treatment of melanoma
Grant 8,980,549 - Markel , et al. March 17, 2		2015-03-17
Antibodies To Carcinoembryonic Antigen-related Cell Adhesion Molecule (ceacam)
App 20140271618 - Markel; Gal ;   et al.		2014-09-18
Modulation of immunity and CEACAM1 activity
Grant 8,815,248 - Markel August 26, 2		2014-08-26
Microrna Patterns For The Diagnosis, Prognosis And Treatment Of Melanoma
App 20140235488 - Markel; Gal ;   et al.		2014-08-21
CEACAM1 mediated protective immunity
Grant 8,735,157 - Markel May 27, 2		2014-05-27
Anti Ceacam1 Antibodies And Methods Of Using Same
App 20140120554 - MARKEL; Gal ;   et al.		2014-05-01
Anti CEACAM1 antibodies and methods of using same
Grant 8,598,322 - Markel , et al. December 3, 2		2013-12-03
Microrna Patterns For The Diagnosis, Prognosis And Treatment Of Melanoma
App 20130197060 - Markel; Gal ;   et al.		2013-08-01
Ceacam Based Antibacterial Agents
App 20130123464 - MARKEL; GAL		2013-05-16
Colored Smoke Module For Cigarette
App 20130032157 - Markel; Gal		2013-02-07
CEACAM based antibacterial agents
Grant 8,298,544 - Markel October 30, 2		2012-10-30
Colored smoke module for cigarette
Grant 8,267,095 - Markel September 18, 2		2012-09-18
Wearable Items Providing Physiological, Environmental And Situational Parameter Monitoring
App 20120136231 - Markel; Gal		2012-05-31
Method Of Diagnosing Cancer
App 20120122122 - Markel; Gal		2012-05-17
Anti Ceacam1 Antibodies And Methods Of Using Same
App 20120100158 - Markel; Gal ;   et al.		2012-04-26
CEACAM1 Based Point-Of-Care Cancer Diagnostic
App 20090181403 - Markel; Gal		2009-07-16
Colored smoke module for cigarette
Grant 7,546,839 - Markel June 16, 2		2009-06-16
Colored Smoke Module For Cigarette
App 20090071488 - Markel; Gal		2009-03-19
CEACAM1 Mediated Protective Immunity
App 20080108140 - Markel; Gal		2008-05-08
Ceacam Based Antibacterial Agents
App 20070293416 - Markel; Gal		2007-12-20
Modulation of Immunity and Ceacam1 Activity
App 20070110668 - Markel; Gal		2007-05-17
CEACAM1 Based Cancer Therapy and Diagnosis
App 20070071758 - Markel; Gal		2007-03-29
Mobile communication device and other devices with cardiovascular monitoring capability
App 20070021677 - Markel; Gal		2007-01-25
Colored smoke module for cigarette
App 20060225754 - Markel; Gal		2006-10-12
Cigarette with colored smoke
App 20060225755 - Markel; Gal		2006-10-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed